Levera RTU 1000 mg Infusion is a specialized formulation designed for the management of epilepsy and seizures. This infusion contains the active ingredient Levetiracetam, which is classified as an antiepileptic medication. The primary purpose of Levera RTU 1000 mg Infusion is to help control and prevent seizures in individuals diagnosed with epilepsy. By stabilizing electrical activity in the brain, Levera RTU 1000 mg Infusion plays a crucial role in reducing the frequency and severity of seizures. The infusion is particularly beneficial for patients who may have difficulty swallowing tablets or require immediate therapeutic intervention. The key composition of Levera RTU 1000 mg Infusion includes 1000 mg of Levetiracetam per 100 ml, making it a potent option for those in need of effective seizure management. As part of its therapeutic category, Levera RTU 1000 mg Infusion is recognized for its efficacy in treating various forms of epilepsy, including partial-onset seizures and generalized tonic-clonic seizures. The formulation works by modulating neurotransmitter release and inhibiting excessive neuronal firing, thereby providing a comprehensive approach to seizure control. Overall, Levera RTU 1000 mg Infusion is an essential treatment option for patients seeking reliable and effective management of their epilepsy symptoms. With its carefully balanced composition and targeted action, Levera RTU 1000 mg Infusion stands out as a vital tool in the therapeutic arsenal against seizures.
Uses & Benefits
Levera RTU 1000 mg Infusion effectively reduces the frequency of seizures in patients with epilepsy.
This infusion formulation is particularly useful for individuals who have difficulty swallowing oral medications.
Levera RTU 1000 mg Infusion helps stabilize electrical activity in the brain, preventing abnormal neuronal firing.
It is indicated for the treatment of partial-onset seizures in adults and children.
Levera RTU 1000 mg Infusion is also effective for generalized tonic-clonic seizures.
The medication can be used as an adjunct therapy for patients already on other antiepileptic drugs.
Levera RTU 1000 mg Infusion provides rapid therapeutic effects, making it suitable for acute seizure management.
This infusion supports improved quality of life by minimizing seizure-related disruptions.
Levera RTU 1000 mg Infusion is beneficial for patients with refractory epilepsy who do not respond to standard treatments.
The formulation is designed to be administered intravenously, ensuring quick absorption and onset of action.
Levera RTU 1000 mg Infusion can be used in hospital settings for immediate seizure control.
This therapy is well-tolerated by most patients, with manageable side effects.
How Levera RTU 1000 mg Infusion works
Levera RTU 1000 mg Infusion works by targeting specific sites on nerve cells to modulate neurotransmitter release and inhibit excessive neuronal firing. This mechanism helps stabilize electrical activity in the brain, effectively preventing seizures.
Levetiracetam, the active ingredient in Levera RTU 1000 mg Infusion, binds to synaptic vesicle protein SV2A, which plays a crucial role in neurotransmitter release.
This binding action reduces the release of excitatory neurotransmitters that can lead to seizure activity.
By suppressing abnormal electrical activity in the brain, Levera RTU 1000 mg Infusion helps maintain normal brain function.
The infusion formulation allows for rapid delivery of the medication into the bloodstream, enhancing its effectiveness during acute seizure episodes.
Levera RTU 1000 mg Infusion does not affect sodium channels or GABA receptors, distinguishing it from many traditional antiepileptic drugs.
This unique mechanism contributes to its favorable side effect profile compared to other antiepileptic medications.
How to use Levera RTU 1000 mg Infusion
Levera RTU 1000 mg Infusion should be administered intravenously by a healthcare professional.
The recommended dosage for adults typically starts at 500 mg twice daily, which may be adjusted based on individual response.
For pediatric patients, dosing is usually based on body weight and should be determined by a physician.
The infusion should be given slowly over a period of time as directed by a healthcare provider.
Frequency of administration may vary; however, maintaining consistent dosing intervals is crucial for optimal seizure control.
Patients should not stop using Levera RTU 1000 mg Infusion abruptly without consulting their doctor, as this may trigger seizures.
Regular monitoring by healthcare professionals is recommended to assess efficacy and adjust dosage as needed.
Ensure that the infusion is stored properly and prepared under sterile conditions to prevent contamination.
Lifestyle Advice
Maintain a consistent daily routine to help manage seizure triggers effectively.
A balanced diet rich in nutrients can support overall health while using Levera RTU 1000 mg Infusion.
Avoid excessive caffeine and alcohol consumption as they may exacerbate seizure activity.
Engage in regular physical activity to promote well-being and reduce stress levels.
Practice relaxation techniques such as yoga or meditation to help manage anxiety related to seizures.
Side Effects
Side Effects
Common side effects of Levera RTU 1000 mg Infusion include sleepiness and fatigue.
Headaches are frequently reported among users of this medication.
Some patients may experience gastrointestinal disturbances such as vomiting or nausea.
Infections may occur due to immune system effects; monitoring is advised.
Serious side effects can include mood changes or behavioral issues; immediate medical attention should be sought if these occur.
If any severe allergic reactions such as rash or swelling occur, discontinue use and consult a doctor promptly.
Patients should inform their healthcare provider about any pre-existing kidney conditions before starting treatment with Levera RTU 1000 mg Infusion.
Precautions and Warnings
Use cautiously if you have kidney, liver, or heart problems.
Inform your doctor if you are pregnant or planning pregnancy; consult on breastfeeding (not recommended during breastfeeding).
Monitor for behavioral changes and mood disturbances, especially during early treatment.
Inform healthcare provider of any allergic reactions like rash, hives, or swelling.
1. What is Levera RTU 1000 mg Infusion used for?
Levera RTU 1000 mg Infusion is primarily used for managing epilepsy and preventing seizures.
2. How should I take Levera RTU 1000 mg Infusion?
Levera RTU 1000 mg Infusion should be administered intravenously by a healthcare professional according to prescribed dosages.
3. What are the common side effects of Levera RTU 1000 mg Infusion?
Common side effects include sleepiness, headache, fatigue, and gastrointestinal issues like vomiting.
4. Can I drink alcohol while using Levera RTU 1000 mg Infusion?
It is advisable to avoid alcohol while taking Levera RTU 1000 mg Infusion due to potential increased drowsiness.
5. Is it safe to use Levera RTU 1000 mg Infusion during pregnancy?
Pregnant women should consult their healthcare provider before using Levera RTU 1000 mg Infusion to discuss potential risks.
6. What should I do if I miss a dose of Levera RTU 1000 mg Infusion?
If you miss a dose, contact your healthcare provider for guidance on how to proceed without disrupting your treatment plan.
7. Are there any interactions with other medications?
Yes, it's important to inform your doctor about all medications you are taking to avoid potential interactions with Levera RTU 1000 mg Infusion.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
SKU
147150
Country of Manufacture
India
Manufacturer Address
Intas Pharmaceuticals Ltd.
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Please refer to the product label for storage information.
Seller
Kogland Commerce Pvt Ltd (TN)
Levera RTU 1000 mg Infusion is a specialized formulation designed for the management of epilepsy and seizures. This infusion contains the active ingredient Levetiracetam, which is classified as an antiepileptic medication. The primary purpose of Levera RTU 1000 mg Infusion is to help control and prevent seizures in individuals diagnosed with epilepsy. By stabilizing electrical activity in the brain, Levera RTU 1000 mg Infusion plays a crucial role in reducing the frequency and severity of seizures. The infusion is particularly beneficial for patients who may have difficulty swallowing tablets or require immediate therapeutic intervention. The key composition of Levera RTU 1000 mg Infusion includes 1000 mg of Levetiracetam per 100 ml, making it a potent option for those in need of effective seizure management. As part of its therapeutic category, Levera RTU 1000 mg Infusion is recognized for its efficacy in treating various forms of epilepsy, including partial-onset seizures and generalized tonic-clonic seizures. The formulation works by modulating neurotransmitter release and inhibiting excessive neuronal firing, thereby providing a comprehensive approach to seizure control. Overall, Levera RTU 1000 mg Infusion is an essential treatment option for patients seeking reliable and effective management of their epilepsy symptoms. With its carefully balanced composition and targeted action, Levera RTU 1000 mg Infusion stands out as a vital tool in the therapeutic arsenal against seizures.
Uses & Benefits
Levera RTU 1000 mg Infusion effectively reduces the frequency of seizures in patients with epilepsy.
This infusion formulation is particularly useful for individuals who have difficulty swallowing oral medications.
Levera RTU 1000 mg Infusion helps stabilize electrical activity in the brain, preventing abnormal neuronal firing.
It is indicated for the treatment of partial-onset seizures in adults and children.
Levera RTU 1000 mg Infusion is also effective for generalized tonic-clonic seizures.
The medication can be used as an adjunct therapy for patients already on other antiepileptic drugs.
Levera RTU 1000 mg Infusion provides rapid therapeutic effects, making it suitable for acute seizure management.
This infusion supports improved quality of life by minimizing seizure-related disruptions.
Levera RTU 1000 mg Infusion is beneficial for patients with refractory epilepsy who do not respond to standard treatments.
The formulation is designed to be administered intravenously, ensuring quick absorption and onset of action.
Levera RTU 1000 mg Infusion can be used in hospital settings for immediate seizure control.
This therapy is well-tolerated by most patients, with manageable side effects.
How Levera RTU 1000 mg Infusion works
Levera RTU 1000 mg Infusion works by targeting specific sites on nerve cells to modulate neurotransmitter release and inhibit excessive neuronal firing. This mechanism helps stabilize electrical activity in the brain, effectively preventing seizures.
Levetiracetam, the active ingredient in Levera RTU 1000 mg Infusion, binds to synaptic vesicle protein SV2A, which plays a crucial role in neurotransmitter release.
This binding action reduces the release of excitatory neurotransmitters that can lead to seizure activity.
By suppressing abnormal electrical activity in the brain, Levera RTU 1000 mg Infusion helps maintain normal brain function.
The infusion formulation allows for rapid delivery of the medication into the bloodstream, enhancing its effectiveness during acute seizure episodes.
Levera RTU 1000 mg Infusion does not affect sodium channels or GABA receptors, distinguishing it from many traditional antiepileptic drugs.
This unique mechanism contributes to its favorable side effect profile compared to other antiepileptic medications.
How to use Levera RTU 1000 mg Infusion
Levera RTU 1000 mg Infusion should be administered intravenously by a healthcare professional.
The recommended dosage for adults typically starts at 500 mg twice daily, which may be adjusted based on individual response.
For pediatric patients, dosing is usually based on body weight and should be determined by a physician.
The infusion should be given slowly over a period of time as directed by a healthcare provider.
Frequency of administration may vary; however, maintaining consistent dosing intervals is crucial for optimal seizure control.
Patients should not stop using Levera RTU 1000 mg Infusion abruptly without consulting their doctor, as this may trigger seizures.
Regular monitoring by healthcare professionals is recommended to assess efficacy and adjust dosage as needed.
Ensure that the infusion is stored properly and prepared under sterile conditions to prevent contamination.
Lifestyle Advice
Maintain a consistent daily routine to help manage seizure triggers effectively.
A balanced diet rich in nutrients can support overall health while using Levera RTU 1000 mg Infusion.
Avoid excessive caffeine and alcohol consumption as they may exacerbate seizure activity.
Engage in regular physical activity to promote well-being and reduce stress levels.
Practice relaxation techniques such as yoga or meditation to help manage anxiety related to seizures.
Side Effects
Side Effects
Common side effects of Levera RTU 1000 mg Infusion include sleepiness and fatigue.
Headaches are frequently reported among users of this medication.
Some patients may experience gastrointestinal disturbances such as vomiting or nausea.
Infections may occur due to immune system effects; monitoring is advised.
Serious side effects can include mood changes or behavioral issues; immediate medical attention should be sought if these occur.
If any severe allergic reactions such as rash or swelling occur, discontinue use and consult a doctor promptly.
Patients should inform their healthcare provider about any pre-existing kidney conditions before starting treatment with Levera RTU 1000 mg Infusion.
Precautions and Warnings
Use cautiously if you have kidney, liver, or heart problems.
Inform your doctor if you are pregnant or planning pregnancy; consult on breastfeeding (not recommended during breastfeeding).
Monitor for behavioral changes and mood disturbances, especially during early treatment.
Inform healthcare provider of any allergic reactions like rash, hives, or swelling.
1. What is Levera RTU 1000 mg Infusion used for?
Levera RTU 1000 mg Infusion is primarily used for managing epilepsy and preventing seizures.
2. How should I take Levera RTU 1000 mg Infusion?
Levera RTU 1000 mg Infusion should be administered intravenously by a healthcare professional according to prescribed dosages.
3. What are the common side effects of Levera RTU 1000 mg Infusion?
Common side effects include sleepiness, headache, fatigue, and gastrointestinal issues like vomiting.
4. Can I drink alcohol while using Levera RTU 1000 mg Infusion?
It is advisable to avoid alcohol while taking Levera RTU 1000 mg Infusion due to potential increased drowsiness.
5. Is it safe to use Levera RTU 1000 mg Infusion during pregnancy?
Pregnant women should consult their healthcare provider before using Levera RTU 1000 mg Infusion to discuss potential risks.
6. What should I do if I miss a dose of Levera RTU 1000 mg Infusion?
If you miss a dose, contact your healthcare provider for guidance on how to proceed without disrupting your treatment plan.
7. Are there any interactions with other medications?
Yes, it's important to inform your doctor about all medications you are taking to avoid potential interactions with Levera RTU 1000 mg Infusion.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
SKU
147150
Country of Manufacture
India
Manufacturer Address
Intas Pharmaceuticals Ltd.
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Please refer to the product label for storage information.
Seller
Kogland Commerce Pvt Ltd (TN)
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Related Products
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
